Is There An Opportunity With Diagnostyka S.A.'s (WSE:DIA) 47% Undervaluation?
Nov 27
Have your own idea? Try our Stock Screener
Polish (WIG) Healthcare Sector Analysis
UpdatedDec 24, 2025
DataAggregated Company Financials
Companies44
- 7D-0.5%
- 3M-8.7%
- 1Y-3.4%
- YTD2.1%
In the last week, the Healthcare industry is flat overall, with Celon Pharma standing out by going down 5.2%. Unfortunately though, the industry is down 3.4% over the past 12 months. Looking forward, earnings are forecast to grow by 25% annually.
Sector Valuation and Performance
Has the Polish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 24 Dec 2025 | zł19.5b | zł19.7b | zł366.1m | 21.4x | 53.2x | 1x |
| Fri, 21 Nov 2025 | zł20.0b | zł19.3b | zł366.8m | 23.3x | 54.5x | 1x |
| Sun, 19 Oct 2025 | zł20.3b | zł19.2b | zł353.2m | 23.7x | 57.4x | 1.1x |
| Tue, 16 Sep 2025 | zł21.1b | zł19.1b | zł388.6m | 22.9x | 54.4x | 1.1x |
| Thu, 14 Aug 2025 | zł20.7b | zł18.8b | zł385.1m | 20.1x | 53.7x | 1.1x |
| Sat, 12 Jul 2025 | zł19.6b | zł17.6b | zł155.9m | 20.6x | 126x | 1.1x |
| Mon, 09 Jun 2025 | zł19.2b | zł17.5b | zł146.5m | 21.1x | 131.4x | 1.1x |
| Wed, 07 May 2025 | zł20.3b | zł17.1b | zł183.6m | 27.4x | 110.7x | 1.2x |
| Fri, 04 Apr 2025 | zł18.8b | zł17.1b | zł90.9m | 31x | 206.8x | 1.1x |
| Sun, 02 Mar 2025 | zł19.1b | zł16.6b | zł114.2m | 26.4x | 167.4x | 1.1x |
| Tue, 28 Jan 2025 | zł15.2b | zł16.7b | zł123.0m | 23.2x | 123.9x | 0.9x |
| Thu, 26 Dec 2024 | zł14.8b | zł16.7b | zł123.0m | 24.6x | 120.3x | 0.9x |
| Sat, 23 Nov 2024 | zł14.7b | zł16.7b | zł125.8m | 21.7x | 116.8x | 0.9x |
| Mon, 21 Oct 2024 | zł15.6b | zł16.4b | zł82.2m | 23.7x | 189.8x | 0.9x |
| Wed, 18 Sep 2024 | zł15.5b | zł16.4b | zł161.0m | 28.5x | 96.3x | 0.9x |
| Fri, 16 Aug 2024 | zł14.8b | zł16.2b | zł132.2m | 32.8x | 112.3x | 0.9x |
| Sun, 14 Jul 2024 | zł15.3b | zł16.2b | zł134.2m | 26.5x | 114.2x | 0.9x |
| Tue, 11 Jun 2024 | zł14.9b | zł16.2b | zł99.9m | 27.1x | 149x | 0.9x |
| Thu, 09 May 2024 | zł14.8b | zł16.0b | zł85.9m | 38.3x | 172.4x | 0.9x |
| Sat, 06 Apr 2024 | zł14.9b | zł15.4b | -zł125,052,549.00 | 39.2x | -119.2x | 1x |
| Mon, 04 Mar 2024 | zł15.1b | zł16.0b | -zł199,514,549.00 | 40.7x | -75.5x | 0.9x |
| Wed, 31 Jan 2024 | zł15.0b | zł15.9b | -zł247,198,884.00 | 34.5x | -60.5x | 0.9x |
| Fri, 29 Dec 2023 | zł15.1b | zł15.9b | -zł245,263,080.00 | 32.5x | -61.6x | 0.9x |
| Sun, 26 Nov 2023 | zł13.9b | zł15.9b | zł148.2m | 30x | 93.4x | 0.9x |
| Tue, 24 Oct 2023 | zł13.6b | zł15.7b | zł114.5m | 31.1x | 118.6x | 0.9x |
| Thu, 21 Sep 2023 | zł14.0b | zł15.7b | zł78.6m | 18.6x | 178.1x | 0.9x |
| Sat, 19 Aug 2023 | zł14.1b | zł15.4b | zł82.1m | 21.1x | 172.2x | 0.9x |
| Mon, 17 Jul 2023 | zł14.6b | zł15.4b | zł101.1m | 26.7x | 144.7x | 1x |
| Wed, 14 Jun 2023 | zł14.1b | zł15.5b | zł184.7m | 24.1x | 76.5x | 0.9x |
| Fri, 12 May 2023 | zł13.9b | zł15.3b | zł201.2m | 27.1x | 69.2x | 0.9x |
| Sun, 09 Apr 2023 | zł13.0b | zł15.4b | zł252.6m | 26.3x | 51.3x | 0.8x |
| Tue, 07 Mar 2023 | zł14.0b | zł15.1b | zł259.2m | 28.7x | 54.1x | 0.9x |
| Thu, 02 Feb 2023 | zł13.5b | zł15.0b | zł237.9m | 26.3x | 56.5x | 0.9x |
| Sat, 31 Dec 2022 | zł12.7b | zł15.0b | zł226.9m | 25.1x | 56.2x | 0.9x |
Price to Earnings Ratio
56.2x
Current Industry PE
- Investors are pessimistic on the Polish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 53.2x which is lower than its 3-year average PE of 88.8x.
- The industry is trading close to its 3-year average PS ratio of 0.97x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 17% per year over the last three years.
- Revenues for these companies have grown 9.6% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Polish Healthcare sector?
| PL Market | 1.74% | |
| Healthcare | -0.45% | |
| Healthtech | 2.13% | |
| Medical Equipment | 0.92% | |
| Healthcare Services | -0.24% | |
| Biotech | -1.17% | |
| Life Sciences | -2.29% | |
| Pharma | -5.45% | |
Industry PE
- Investors are most optimistic about the Healthtech industry, which is trading close to its 3-year average PE ratio of 25.7x.
- Analysts are expecting annual earnings growth of 18.2%, which is higher than its past year's earnings growth of 1.3% per year.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 59% over the next 5 years.
- This is better than its past earnings growth rate of 18% per year.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 16% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SNT Synektik Spólka Akcyjna | zł275.00 | 2.2% +zł51.2m | 44.0% | PE25.3x | |
| NEU NEUCA | zł822.00 | 0.6% +zł22.2m | -7.5% | PE23.7x | |
| ICE Medinice | zł16.96 | 10.0% +zł11.9m | 126.4% | PE3.5x | |
| CTX Captor Therapeutics Spolka Akcyjna | zł69.80 | 2.9% +zł11.1m | 67.0% | PS51x | |
| SDS SDS Optic Spolka Akcyjna | zł6.30 | 37.0% +zł10.1m | -34.7% | n/a |
